Price
Target price
€18.03
€18.03
-3.450%
-0.645
-3.450%
€60.13
15:35 / Tradegate
WKN: A2AG6H / Symbol: NTLA / Name: Intellia / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Intellia Therapeutics Inc Stock
Intellia Therapeutics Inc took a tumble today and lost -€0.645 (-3.450%).
Intellia Therapeutics Inc is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
Based on the current price of 18.03 € the target price of 60 € shows a potential of 232.78% for Intellia Therapeutics Inc which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Intellia Therapeutics Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Intellia Therapeutics Inc in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Intellia Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | -3.450% | -6.811% | -24.819% | -43.546% | -35.492% | -71.154% | 22.419% |
| Chromadex Corp | -0.630% | -11.732% | -9.714% | 152.800% | 135.821% | -48.618% | - |
| Organovo Holdings Inc. | -4.130% | -15.818% | -3.037% | -43.742% | -9.747% | -88.013% | -94.745% |
| VBI Vaccines Inc. | -3.030% | -0.355% | 7.885% | -78.340% | 5.849% | -99.192% | -98.980% |
Comments
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for NTLA provided by MarketBeat
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Morgan Stanley from $90.00 to $85.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for NTLA provided by MarketBeat
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Raymond James from $78.00 to $57.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for NTLA provided by MarketBeat
News
2 Stocks Down 30% to Buy Right Now
The bull market is roaring higher, and many growth stocks have led the gains -- but this doesn't mean your opportunity to buy growth stocks for a good price is over. Plenty of players with great
Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.
Cathie Wood is known for her investments in disruptive technologies that are changing or have the potential to change the way things are done. She's built a solid reputation as a stock picker
Better Cathie Wood Stock: Moderna vs. Intellia
Cathie Wood's latest stocks shopping spree included several healthcare innovators -- and she picked them up for a bargain. Wood isn't intimidated by shares that have wallowed in the doldrums because